The ascendancy of Viagra and its effect on the drug landscape presents a intricate question for shareholders. While the early sales data were impressive, the intellectual property has lapsed, leading to a deluge of https://estelleitty542218.yomoblog.com/48720371/the-blue-pill-and-big-pharma-a-dangerous-bet